End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
60.13
CNY
|
-0.94%
|
|
+4.27%
|
+7.90%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
10,738
|
27,813
|
38,631
|
23,972
|
26,523
|
28,618
|
-
|
Enterprise Value (EV)
1 |
10,738
|
27,813
|
38,631
|
23,972
|
26,523
|
28,618
|
28,618
|
P/E ratio
|
36.7
x
|
67.3
x
|
113
x
|
45.7
x
|
45.8
x
|
34.4
x
|
22.1
x
|
Yield
|
-
|
0.3%
|
0.26%
|
0.64%
|
0.65%
|
0.86%
|
1.26%
|
Capitalization / Revenue
|
5.86
x
|
12.2
x
|
10.2
x
|
5.63
x
|
5.6
x
|
5.06
x
|
3.57
x
|
EV / Revenue
|
5.86
x
|
12.2
x
|
10.2
x
|
5.63
x
|
5.6
x
|
5.06
x
|
3.57
x
|
EV / EBITDA
|
22.3
x
|
44.4
x
|
65.8
x
|
28.7
x
|
26.8
x
|
21.1
x
|
16.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-28.4
x
|
203
x
|
119
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-3.52%
|
0.49%
|
0.84%
|
Price to Book
|
2.43
x
|
5.9
x
|
6.45
x
|
3.69
x
|
3.84
x
|
3.78
x
|
3.23
x
|
Nbr of stocks (in thousands)
|
462,854
|
462,854
|
475,928
|
475,928
|
475,928
|
475,928
|
-
|
Reference price
2 |
23.20
|
60.09
|
81.17
|
50.37
|
55.73
|
60.13
|
60.13
|
Announcement Date
|
2/27/20
|
4/13/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,832
|
2,273
|
3,782
|
4,259
|
4,738
|
5,660
|
8,015
|
EBITDA
1 |
480.9
|
625.8
|
586.9
|
835.2
|
988.6
|
1,359
|
1,752
|
EBIT
1 |
381
|
500.1
|
418.4
|
654.3
|
758.3
|
1,052
|
1,600
|
Operating Margin
|
20.79%
|
22%
|
11.06%
|
15.36%
|
16%
|
18.59%
|
19.96%
|
Earnings before Tax (EBT)
1 |
379.9
|
495.5
|
407.1
|
653.7
|
739.4
|
1,052
|
1,597
|
Net income
1 |
292.6
|
413.2
|
334.8
|
524.3
|
579.5
|
835
|
1,293
|
Net margin
|
15.97%
|
18.18%
|
8.85%
|
12.31%
|
12.23%
|
14.75%
|
16.14%
|
EPS
2 |
0.6323
|
0.8927
|
0.7165
|
1.102
|
1.218
|
1.750
|
2.718
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-933
|
141
|
241
|
FCF margin
|
-
|
-
|
-
|
-
|
-19.69%
|
2.49%
|
3.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
10.38%
|
13.75%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
16.89%
|
18.63%
|
Dividend per Share
2 |
-
|
0.1800
|
0.2100
|
0.3200
|
0.3600
|
0.5200
|
0.7567
|
Announcement Date
|
2/27/20
|
4/13/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
281.4
|
Net margin
|
-
|
EPS
2 |
0.5913
|
Dividend per Share
|
-
|
Announcement Date
|
8/29/22
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-933
|
141
|
241
|
ROE (net income / shareholders' equity)
|
6.81%
|
9.07%
|
6.49%
|
9.61%
|
8.39%
|
11.5%
|
14.8%
|
ROA (Net income/ Total Assets)
|
5.16%
|
7.52%
|
5.27%
|
5.86%
|
-
|
6.4%
|
8.87%
|
Assets
1 |
5,677
|
5,497
|
6,358
|
8,946
|
-
|
13,047
|
14,586
|
Book Value Per Share
2 |
9.540
|
10.20
|
12.60
|
13.60
|
14.50
|
15.90
|
18.60
|
Cash Flow per Share
2 |
0.7200
|
0.4300
|
0.6700
|
1.420
|
1.240
|
1.780
|
2.690
|
Capex
1 |
195
|
564
|
543
|
1,458
|
1,522
|
1,236
|
1,016
|
Capex / Sales
|
10.64%
|
24.81%
|
14.37%
|
34.24%
|
32.13%
|
21.84%
|
12.68%
|
Announcement Date
|
2/27/20
|
4/13/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Last Close Price
60.13
CNY Average target price
71.6
CNY Spread / Average Target +19.08% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.90% | 3.95B | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|